Is Healthpeak Properties, Inc. (Old) overvalued or undervalued?
As of February 3, 2025, Healthpeak Properties, Inc. is considered a very attractive investment due to its undervaluation indicated by a high P/E ratio of 38 compared to peers, a favorable EV to EBITDA ratio of 7.48, and strong growth prospects despite recent underperformance against the S&P 500.
As of 3 February 2025, the valuation grade for Healthpeak Properties, Inc. has moved from fair to very attractive, indicating a significant positive shift in its perceived value. The company appears to be undervalued given its current P/E ratio of 38 compared to peers like Kimco Realty Corp. at 25.49 and W.P. Carey, Inc. at 29.18, suggesting that Healthpeak may be trading at a premium relative to its competitors. Additionally, the EV to EBITDA ratio stands at 7.48, while the industry average for similar companies is higher, reinforcing the undervaluation perspective.Key financial ratios further support this conclusion, with a Price to Book Value of 1.47 and a PEG Ratio of 32.79, indicating that the stock may be undervalued in relation to its growth prospects. Despite recent underperformance against the S&P 500, with a year-to-date return of -13.71% compared to the index's 2.44%, the fundamentals suggest that Healthpeak Properties, Inc. is positioned for potential recovery and growth, making it an attractive investment opportunity at its current price of 17.49.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
